Morath, Christian ORCID: https://orcid.org/0000-0003-2218-7817; Schmitt, Anita; Schmitt, Michael; Wang, Lei; Kleist, Christian; Opelz, Gerhard; Süsal, Caner; Tran, T. Hien; Scherer, Sabine; Schwenger, Vedat; Kemmner, Stephan ORCID: https://orcid.org/0000-0002-1242-4914; Fischereder, Michael; Stangl, Manfred; Hauser, Ingeborg A.; Sommerer, Claudia; Nusshag, Christian; Kälble, Florian; Speer, Claudius ORCID: https://orcid.org/0000-0002-3668-5916; Benning, Louise; Bischofs, Christian; Sauer, Sandra; Schubert, Maria-Luisa; Kunz, Alexander; Hückelhoven-Krauss, Angela; Neuber, Brigitte; Mehrabi, Arianeb ORCID: https://orcid.org/0000-0001-6163-1525; Schwab, Constantin; Waldherr, Rüdiger; Sander, Anja; Büsch, Christopher; Czock, David; Böhmig, Georg A; Reiser, Jochen; Roers, Axel; Müller-Tidow, Carsten; Terness, Peter; Zeier, Martin; Daniel, Volker und Schaier, Matthias
(2022):
Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial.
In: BMJ Open, Bd. 12, Nr. 11, e066128
[PDF, 796kB]
- Dokument bearbeiten